Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 10 min ago
PreprintAll rights reservedmedRxiv

Site-specific immune remodeling underlies resistance to dual immune checkpoint blockade in metastatic colorectal cancer

  • I. Baraibar
  • S. Morabito
  • G. Deuner-Cos
  • G. Caratu
  • J. L. Melero
  • M. Berasategi
  • M. Soto
  • M. Grzelak
  • P. Nieto
  • D. Maspero
  • F. Salva
  • N. Saoudi
16 more authors
  • J. Ros
  • R. Perez-Lopez
  • A. Gros
  • G. Villacampa
  • N. Roson
  • J. Carmona
  • A. Garcia
  • A. Lambert
  • N. Martinez-Martin
  • P. Casbas-Hernandez
  • J. Zeron-Medina
  • J. Tabernero
  • A. Rotem
  • J. C. Nieto
  • E. Elez
  • H. Heyn
Read full textPDFDOICite

Related

  1. ADAM12 in a stromal-checkpoint framework: integrating tumor microenvironment remodeling and therapy resistance in solid tumors.
    Shaochun Liu, Jian Xu, Han Zhang +7
    Cell communication and signaling : CCSPeer-reviewedCC BYFull text1 citedOncologyEurope PMCDOAJ
  2. Extracellular matrix collagen remodeling predicts resistance to immune checkpoint blockade in mismatch repair-deficient endometrial cancer
    Etienne Rouleau, Alexandra Leary, Jakob Nikolas Kather +13
    Journal for ImmunoTherapy of CancerPeer-reviewedCC BYFull textOncologyDOAJ
  3. 270 AgenT-797, an allogeneic iNKT cell therapy, enables tumor-cell killing in a human organoid model of immune checkpoint inhibitor–refractory colorectal cancer liver metastases
    Nils-Petter Rudqvist, Bishnu Joshi, Dhan Chand +8
    Journal for ImmunoTherapy of CancerPeer-reviewedCC BYFull textOncologyDOAJ
  4. Association between primary-site surgery and overall survival in non-metastatic and metastatic colorectal cancer: a population-based study using the Surveillance, Epidemiology, and End Results database
    Xueru Fan, Tianzi Luo, Zelun Li +2
    Translational cancer researchPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  5. HER3 mediates metabolic reprogramming in metastatic colorectal and pancreatic cancer
    M. Rathore, C. Wei, J. Winter +1
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv

Cite

BibTeXRIS
BibTeX
@misc{baraibar2026sitespecific,
  title = {{Site-specific immune remodeling underlies resistance to dual immune checkpoint blockade in metastatic colorectal cancer}},
  author = {I. Baraibar and S. Morabito and G. Deuner-Cos and G. Caratu and J. L. Melero and M. Berasategi and M. Soto and M. Grzelak and P. Nieto and D. Maspero and F. Salva and N. Saoudi and J. Ros and R. Perez-Lopez and A. Gros and G. Villacampa and N. Roson and J. Carmona and A. Garcia and A. Lambert and N. Martinez-Martin and P. Casbas-Hernandez and J. Zeron-Medina and J. Tabernero and A. Rotem and J. C. Nieto and E. Elez and H. Heyn},
  howpublished = {medRxiv},
  year = {2026},
  month = oct,
  doi = {10.64898/2026.10.23.26365904},
  url = {https://www.medrxiv.org/content/10.64898/2026.10.23.26365904v1},
}
RIS
TY  - UNPB
TI  - Site-specific immune remodeling underlies resistance to dual immune checkpoint blockade in metastatic colorectal cancer
AU  - I. Baraibar
AU  - S. Morabito
AU  - G. Deuner-Cos
AU  - G. Caratu
AU  - J. L. Melero
AU  - M. Berasategi
AU  - M. Soto
AU  - M. Grzelak
AU  - P. Nieto
AU  - D. Maspero
AU  - F. Salva
AU  - N. Saoudi
AU  - J. Ros
AU  - R. Perez-Lopez
AU  - A. Gros
AU  - G. Villacampa
AU  - N. Roson
AU  - J. Carmona
AU  - A. Garcia
AU  - A. Lambert
AU  - N. Martinez-Martin
AU  - P. Casbas-Hernandez
AU  - J. Zeron-Medina
AU  - J. Tabernero
AU  - A. Rotem
AU  - J. C. Nieto
AU  - E. Elez
AU  - H. Heyn
PY  - 2026
DA  - 2026/10/23
PB  - medRxiv
DO  - 10.64898/2026.10.23.26365904
UR  - https://www.medrxiv.org/content/10.64898/2026.10.23.26365904v1
ER  -